Nimodipine 30 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet/ Injection
Available Strengths: 30 mg
Reference Brands: Nimotop (USA)
Category: Neurology
Nimodipine is a Neurology product available as Tablet/ Injection in strengths 30 mg. It corresponds to the reference brand Nimotop (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Nimodipine is a second-generation 1,4-dihydropyridine calcium channel blocker that was initially approved for the management of hypertension. In current clinical practice, it is primarily used to prevent and manage cerebral vasospasm following subarachnoid hemorrhage, a condition that can lead to severe neurological complications. Nimodipine acts by selectively blocking calcium channels in cerebral blood vessels, resulting in vasodilation and improved cerebral blood flow, which helps reduce the risk of ischemic brain injury.
Nimodipine is available in multiple dosage forms, including oral capsules, oral solutions, and intravenous infusions, allowing flexibility in administration based on patient condition and clinical setting. Its ability to cross the blood–brain barrier makes it particularly effective in targeting cerebral vasculature. In addition to its approved indication, nimodipine has been explored for off-label uses in various neurological conditions.
Appropriate administration of nimodipine requires careful consideration of dosing schedules, contraindications, and potential adverse effects such as hypotension, headache, and gastrointestinal disturbances. Continuous monitoring by healthcare professionals is essential to optimize therapeutic outcomes and minimize risks. Proper understanding of nimodipine’s pharmacology supports effective treatment and improved patient outcomes in subarachnoid hemorrhage management.
Nimodipine — third party manufacturing & bulk supply
Nimodipine 30 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Nimodipine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Nimodipine →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Nimodipine is used to reduce the risk of neurological damage caused by cerebral vasospasm following subarachnoid hemorrhage.
Nimodipine is a dihydropyridine calcium channel blocker that selectively acts on cerebral blood vessels.
The primary trade name of nimodipine is Nimotop.
Nimodipine is manufactured by multiple pharmaceutical companies worldwide under both branded and generic formulations.
The generic name is nimodipine.
The brand name is Nimotop.
Nimodipine is manufactured in regulated pharmaceutical facilities across the USA, EU, and UK.
Related Products
Valproic Acid
Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
View DetailsQuick Response Guaranteed | Verified Suppliers